Companies Related to "Therapy With Bevacizumab (BEV), Doxorubicin, and Cyclophosphamide Followed by BEV, Docetaxel, and Capecitabine Before Surgery Followed by BEV Alone After Surgery for Women With Locally Advanced Breast Cancer" [Most Relevant Company Matches] - Page: 3 RSS

08:03 EST 20th January 2019 | BioPortfolio

Here are the most relevant search results for "Therapy With Bevacizumab (BEV), Doxorubicin, and Cyclophosphamide Followed by BEV, Docetaxel, and Capecitabine Before Surgery Followed by BEV Alone After Surgery for Women With Locally Advanced Breast Cancer" found in our extensive corporate database of over 50,000 company records.

Showing "Therapy With Bevacizumab Doxorubicin Cyclophosphamide Followed Docetaxel Capecitabine" Companies 51–75 of 1,100+

Probably Relevant

ViewRay Incorporated

ViewRay Incorporated is developing an advanced system to treat cancer patients: the world's first real-time MRI guided radiation therapy device. The Renaissance(TM) System technology will continuously image the patient in three dimensions during radiation therapy delivery. This real time imaging will control the delivery of the radiation therapy and record the dose delivered to the patient, allowi...

CarrollDrugs.Com - The online department of Taneytown Pharmacy

Carroll Drugs offers full line pharmacy services and features hormone replacement therapy with local and national delivery. In addition to traditional prescriptions, we compound medications specific to each patient by order of a physician, such as hormone replacement therapy. E-mail or call us us to find out about our VERY reasonable prices on drugs and compounds like bio-identical hormone replac...

Cell Therapy Foundation

The Cell Therapy Foundation is a not-for-profit organization committed to advancing the treatment of disease using adult stem cells. Emerging as a leader in raising funds for adult stem cell research, Cell Therapy Foundation strives to increase awareness about adult stem cells, to fund adult stem cell research addressing several specific diseases, and to accelerate the rate of research and clini...

BSD Medical

BSD Medical Corporation (AMEX: BSM) develops, manufactures, markets and services systems to treat cancer and benign diseases using heat therapy delivered using focused radio frequency (RF) and microwave energy. BSD Medical is also making major progress in the application of its technology for other therapies. Microwave and RF hyperthermia therapy has been shown to substantially improve local con...

Aastrom Biosciences Incorporated

Aastrom Biosciences, Inc. (Nasdaq: ASTM) is developing automated cell therapy systems designed to enable on-site cell production for therapeutic procedures using living cells in patients treated for cancer and other diseases and cells used in the restoration of normal tissues. The Company has received approval to affix the CE Mark to the various components of the AastromReplicell™ System, the SC...

Cytonet GmbH & Co. KG

"Cytonet provides successful solutions to heal life-threatening diseases by using pharmaceuticals based on human cells while using the competence in cell-therapy to extend the world-wide leading position in in vitro and in vivo therapy of heaviest disease of vital parts, especially the liver."


TrakCel's cell therapy process management solution improves clinical study efficacy and accelerates product scale-up/scale-out by implementing communications technology to integrate the supply chain from end-to-end. The technology provides interactive instructions to professionals within the cell therapy supply chain and gives stakeholders on-demand visibi...

iACT Center

Animal-assisted & Creative Therapies (iACT) is a private company providing individualized therapy and rehabilitation for special needs children and adults. ACT is the advanced and improved program developed by Dr. David Nathanson as part of the evolution of his previous company, Dolphin Human Therapy (DHT).

Cyberonics Incorporated

Cyberonics, Inc. (NASDAQ: CYBX) pioneered the Vagus Nerve Stimulation (VNS Therapy™) System. Founded in 1987 to design, develop and market implantable medical devices for the treatment of epilepsy and other debilitating neurological disorders, Cyberonics has emerged as a leader in the neuromodulation industry. The VNS Therapy System uses a surgically implanted medical device that delivers elec...

QLT PhotoTherapeutics Incorporated

QLT Inc. is a global biopharmaceutical company dedicated to the discovery, development and commercialization of innovative therapies to treat cancer, eye diseases and immune disorders. Combining expertise in ophthalmology, oncology and photodynamic therapy, QLT has commercialized two products to date, including Visudyne® therapy which is the most successfully launched ophthalmology product ever.


Founded in 1998 on the initiative of researchers from the Academic Medical Center (AMC) in Amsterdam, AMT has become a leader in the field of human gene therapy. A pioneer in the development of gene therapy AMT has used its scientific know-how and expertise to build up a strong research and clinical development program filling an unmet medical need for therapy of severe (orphan) diseases in the fo...

Cyberonics, Inc.

Cyberonics, Inc. (NASDAQ:CYBX) is a medical technology company with core expertise in neuromodulation. The company developed and markets the Vagus Nerve Stimulation (VNS) Therapy System, which is FDA-approved for the treatment of refractory epilepsy and treatment-resistant depression. The VNS Therapy System uses a surgically implanted medical device that delivers pulsed electrical signals to the...

Gulmay Medical Limited

Gulmay Medical Limited commenced operation in 1995 to develop, design, manufacture and market x-ray therapy equipment specifically to the medical market and now has an installed base of superficial and orthovoltage equipment in over 100 hospitals worldwide.Gulmay Medical customers benefit from the groups integrated development philosophy. Offering a turnkey approach for therapy centres involving a...

BioElectronics Corporation

BioElectronics Corporation is the maker of ActiPatch® Therapy, RecoveryRx(TM) Devices, HealFast(TM) Therapy ( and the Allay(TM) family of inexpensive, disposable drug-free anti-inflammatory devices. For more information please see

Inogen, Inc.

Inogen is innovation in oxygen therapy. We are a medical technology company that develops, manufactures and markets innovative oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. For more information, please visit

CDH Proton Center

CDH Proton Center, A ProCure Center, Warrenville, Ill., is one of a handful of facilities in the country that offer proton therapy, an advanced form of radiation to treat cancer. The four-room, 60,000 sq. ft. Center, opened Oct. 19, 2010, is the first for Illinois and has the capacity to treat up to 1,500 patients a year. The precision of proton therapy sp...

Samson Showalter Lepore Vascular Specialists

Our practice is the only medical practice in the Tri-county area dedicated to the treatment of patients with disorders of the veins and arteries, the Vascular System. Unlike most vascular surgical groups, we are also uniquely trained and experienced to offer all forms of diagnosis and therapy including:medications exercise therapy endovascular diagnosis and treatments (Angiography, Balloon angiopl...

Midwest Institute for Interventional Therapy

A team of research professionals, internationally known Interventional Radiologists, and support staff from one of the top universities in the country, together form the Midwest Institute for Interventional Therapy in Peoria, Illinois. The Radiologists in this group have published hundreds of articles and are now in their 13th year of directing the annual seminar. From the beginning MIIT has pre...

Nanospectra Biosciences, Inc.

Nanospectra Biosciences has an exclusive license to a new class of materials developed at Rice University, AuroShellâ„¢ microparticles (originally called nanoshells). While there are numerous therapeutic, diagnostic and industrial commercial opportunities, Nanospectra is focused on the development of a therapy broadly applicable to virtually all solid tumors, AuroLaseâ„¢ Cancer Therapy.

Collateral Therapeutics Incorporated

Collateral's initial non-surgical gene therapy products under investigation are designed to promote and enhance angiogenesis, a natural biological process which results in the growth of additional blood vessels, to increase levels of blood flow to oxygen-deprived tissues. The Company's angiogenic products are administered using methods of gene therapy based on non-surgical adenoviral vector delive...

Brief Strategic Family Therapy® Institute

BSFT™ is a short-term, structured, problem-focused, and practical approach to the treatment of adolescent conduct problems, associations with antisocial peers, early drug use and the accompanying maladaptive family interactions (relations), all of which are recognized risk factors for delinquent behavior and substance abuse. BSFT™ strengthens ado...


ViroLogic, a privately held South San Francisco-based biotechnology company, is a leader in the development of novel therapy guidance tools to enable patients, physicians, and medical reimbursers to make rational treatment decisions in the management of viral diseases. The company's proprietary technology is also being used in the fields of viral pharmacogenomics to identify, analyze, and select n...

Waratah Pharmaceuticals

Waratah is a dynamic young biopharmaceutical company founded in April 2000 as a spin-off of RTP Pharma Inc. to develop and commercialize products for its novel, patented therapy – Islet Neogenesis Therapy (I.N.T.™) for the treatment of insulin-dependent diabetes. Diabetes is a disease in which the body does not produce or properly use insulin because of damaged or destroyed insulin producing i...

Rocket Pharmaceuticals, Inc.

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) (“Rocket”) is an emerging, clinical-stage biotechnology company focused on developing first-in-class gene therapy treatment options for rare, undertreated diseases. Rocket’s multi-platform development approach applies the well-established lentiviral vector (LVV) and adeno-associated viral vector (AA...


MOLOGEN is specializing in selected areas of Molecular Medicine. Our areas of competence are gene expression, gene therapy and bioinformatics. We are dedicated to the development of DNA expression and delivery technologies for human and veterinary applications, leading to products for gene therapy, and prophylactic and therapeutic DNA-based vaccines

More From BioPortfolio on "Therapy With Bevacizumab (BEV), Doxorubicin, and Cyclophosphamide Followed by BEV, Docetaxel, and Capecitabine Before Surgery Followed by BEV Alone After Surgery for Women With Locally Advanced Breast Cancer"

Quick Search


Corporate Database Quicklinks